DANIELLE REMUS: Open Payments
NPI 1528766417 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 32 payments from 11 companies in 2025. Trend: 2023 $1,337 · 2024 $3,716 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| Madrigal Pharmaceuticals | 2 | $168 |
| PFIZER INC. | 5 | $85 |
| Janssen Biotech, Inc. | 3 | $78 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $20 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, XELJANZ, LINZESS, ZENPEP, DUPIXENT, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
